Health ❯ Medicine ❯ Pharmaceuticals

Drug Development

Clinical Trials Obesity Treatments Weight Loss Drugs Alzheimer's Disease Cholesterol Management Inflammatory Bowel Disease Chemotherapeutic Drugs Epilepsy Treatment Obesity Treatment Sildenafil

5 ARTICLES

4w ago

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

The company says it will review physician requests under narrow medical criteria to supply a small number of patients with the drug before a planned FDA filing.

6 ARTICLES

last mo.

Lilly Will Seek FDA Approval for Retatrutide in Q1 2027 After Two More Positive Phase 3 Trials

3 ARTICLES

2mo ago

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

5 ARTICLES

6mo ago

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

5 ARTICLES

6mo ago

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

3 ARTICLES

7mo ago

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

5 ARTICLES

8mo ago

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

7 ARTICLES

8mo ago

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

4 ARTICLES

8mo ago

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

4 ARTICLES

9mo ago

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

5 ARTICLES

9mo ago

Novo Nordisk Halts Phase-3 Alzheimer’s Trial of Semaglutide After Failure to Slow Decline

11 ARTICLES

9mo ago

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

6 ARTICLES

10mo ago

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

9 ARTICLES

10mo ago

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

8 ARTICLES

10mo ago

Google’s ‘Quantum Echoes’ Claims 13,000× Speedup on Willow in Peer-Reviewed Study

7 ARTICLES

11mo ago

Trump Urges Pregnant Women to Avoid Paracetamol Over Autism Risk

3 ARTICLES

last yr.

Scientists Renew Push to Ban 'Mirror Life' Research After New Warning

Drug Development

Eli Lilly Opens Limited Early Access to Experimental Obesity Drug Retatrutide

Lilly Will Seek FDA Approval for Retatrutide in Q1 2027 After Two More Positive Phase 3 Trials

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

FDA Grants Orphan Drug Status to Immutep’s Efti for Soft Tissue Sarcoma

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

Never miss stories about

Drug Development

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Novo Nordisk Halts Phase-3 Alzheimer’s Trial of Semaglutide After Failure to Slow Decline

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

Google’s ‘Quantum Echoes’ Claims 13,000× Speedup on Willow in Peer-Reviewed Study

Trump Urges Pregnant Women to Avoid Paracetamol Over Autism Risk

Scientists Renew Push to Ban 'Mirror Life' Research After New Warning

Never miss stories about

Drug Development